Human embryonic stem cells:: Current technologies and emerging industrial applications

被引:63
作者
Ameen, Caroline [1 ]
Strehl, Raimund [1 ]
Bjorquist, Petter [1 ]
Lindahl, Anders [2 ]
Hyllner, Johan [1 ]
Sartipy, Peter [1 ]
机构
[1] Cellartis AB, Gothenburg 41346, Sweden
[2] Sahlgrens Univ Hosp, Inst Biomed, Dept Clin Chem & Transfus Med, Gothenburg, Sweden
基金
美国国家卫生研究院;
关键词
human embryonic stem cells; differentiation; cardiomyocytes; hepatocytes; drug discovery; toxicology; regenerative medicine;
D O I
10.1016/j.critrevonc.2007.06.012
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The efficiency and accuracy of the drug development process is severely restricted by the lack of functional human cell systems. However, the successful derivation of pluripotent human embryonic stem (hES) cell lines in the late 1990s is expected to revolutionize biomedical research in many areas. Due to their growth capacity and unique developmental potential to differentiate into almost any cell type of the human body, hES cells have opened novel avenues both in basic and applied research as well as for therapeutic applications. In this review we describe, from an industrial perspective, the basic science that underlies the hES cell technology and discuss the current and future prospects for hES cells in novel and improved stem cell based applications for drug discovery, toxicity testing as well as regenerative medicine. (c) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:54 / 80
页数:27
相关论文
共 261 条
  • [61] PRIMITIVE-STREAK ORIGIN OF THE CARDIOVASCULAR-SYSTEM IN AVIAN EMBRYOS
    GARCIAMARTINEZ, V
    SCHOENWOLF, GC
    [J]. DEVELOPMENTAL BIOLOGY, 1993, 159 (02) : 706 - 719
  • [62] Validation of the embryonic stem cell test in the international ECVAM validation study on three in vitro embryotoxicity tests
    Genschow, E
    Spielmann, H
    Scholz, G
    Pohl, I
    Seiler, A
    Clemann, N
    Bremer, S
    Becker, K
    [J]. ATLA-ALTERNATIVES TO LABORATORY ANIMALS, 2004, 32 (03): : 209 - 244
  • [63] Bioreactor cultivation enhances the efficiency of human embryoid body (hEB) formation and differentiation
    Gerecht-Nir, S
    Cohen, S
    Itskovitz-Eldor, J
    [J]. BIOTECHNOLOGY AND BIOENGINEERING, 2004, 86 (05) : 493 - 502
  • [64] CYTOMEGALOVIRUS REPLICATES IN DIFFERENTIATED BUT NOT IN UNDIFFERENTIATED HUMAN EMBRYONAL CARCINOMA-CELLS
    GONCZOL, E
    ANDREWS, PW
    PLOTKIN, SA
    [J]. SCIENCE, 1984, 224 (4645) : 159 - 161
  • [65] BMP-4 is required for hepatic specification of mouse embryonic stem cell-derived definitive endoderm
    Gouon-Evans, Valerie
    Boussemart, Lise
    Gadue, Paul
    Nierhoff, Dirk
    Koehler, Christoph I.
    Kubo, Atsushi
    Shafritz, David A.
    Keller, Gordon
    [J]. NATURE BIOTECHNOLOGY, 2006, 24 (11) : 1402 - 1411
  • [66] Endoderm development - from patterning to organogenesis
    Grapin-Botton, A
    Melton, DA
    [J]. TRENDS IN GENETICS, 2000, 16 (03) : 124 - 130
  • [67] Grepin C, 1997, DEVELOPMENT, V124, P2387
  • [68] The involvement of key DNA repair pathways in the formation of chromosome rearrangements in embryonic stem cells
    Griffin, C
    de Waard, H
    Deans, B
    Thacker, J
    [J]. DNA REPAIR, 2005, 4 (09) : 1019 - 1027
  • [69] The MRP-related and BCRP/ABCG2 multidrug resistance proteins: Biology, substrate specificity and regulation
    Haimeur, A
    Conseil, G
    Deeley, RG
    Cole, SPC
    [J]. CURRENT DRUG METABOLISM, 2004, 5 (01) : 21 - 53
  • [70] Hepatic maturation in differentiating embryonic stem cells in vitro
    Hamazaki, T
    Iiboshi, Y
    Oka, M
    Papst, PJ
    Meacham, AM
    Zon, LI
    Terada, N
    [J]. FEBS LETTERS, 2001, 497 (01) : 15 - 19